Target intelligence / Profile preview

Mitochondrial F1FO ATP synthase complex (Complex V)

Target
Complex V
Molecular classification
Enzyme, Transporter, Oxidative phosphorylation complex
01

Overview

The mitochondrial F1FO ATP synthase complex, also known as Complex V, is a multi-subunit enzyme located in the inner mitochondrial membrane that plays a critical role in cellular energy production [StatPearls: NBK557482]. It utilizes the electrochemical proton gradient generated by the electron transport chain to catalyze the synthesis of adenosine triphosphate (ATP) from adenosine diphosphate (ADP) and inorganic phosphate [UniProt: P06576]. The complex consists of two functional domains: the F1 catalytic domain, which protrudes into the mitochondrial matrix, and the FO membrane-embedded domain, which facilitates proton translocation [PubMed: 30104378]. Beyond its primary role in bioenergetics, the ATP synthase is involved in the formation of the mitochondrial permeability transition pore (mPTP), influencing cell death pathways such as apoptosis and necrosis [PubMed: 29123138]. Dysregulation of this complex is linked to various pathologies, including mitochondrial DNA disorders like Leigh syndrome and NARP (neurogenic muscle weakness, ataxia, and retinitis pigmentosa), as well as cancer, where metabolic reprogramming occurs [PubMed: 25659444]. Pharmacological targeting of the ATP synthase is explored in oncology to induce metabolic stress in cancer cells and in the treatment of infectious diseases, although selectivity remains a significant challenge due to its essential role in normal physiology [PubMed: 29512651].

Other names
F1F0-ATP synthaseMitochondrial ATP synthaseH+-transporting ATPaseATP synthase complexFoF1-ATPaseATP synthase, H+ transporting, mitochondrial F1 complex
02

Mechanism of action

Inhibition of the FO subunit to block proton translocation or inhibition of the F1 subunit to prevent ATP synthesis and hydrolysis [PubMed: 30104378].

03

Biological functions

ATP synthesisProton transportMitochondrial membrane potential maintenanceApoptosisMetabolic regulation
04

Disease associations

Mitochondrial diseaseCancerCardiovascular diseaseNeurodegenerative diseaseInfection
05

Safety considerations

Systemic toxicityMitochondrial dysfunctionLactic acidosisCardiotoxicityNeurotoxicity
06

Interacting drugs

Oligomycin

6 more in the full profile.

07

Biomarkers

ATP/ADP ratioMitochondrial membrane potentialLactate levelsOxygen consumption rate (OCR)

Beyond the preview

Go deeper on Mitochondrial F1FO ATP synthase complex (Complex V).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial F1FO ATP synthase complex (Complex V).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call